Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 2/2014

01-04-2014

Skin Manifestations of Primary Immune Deficiency

Author: Heather Lehman

Published in: Clinical Reviews in Allergy & Immunology | Issue 2/2014

Login to get access

Abstract

Cutaneous manifestations are common in primary immune deficiency diseases, affecting between 40 % and 70 % of patients with diagnosed primary immune deficiency. Skin infections characterize many primary immune deficiencies, but there are also frequent noninfectious cutaneous manifestations seen in many of these disorders, including eczematous lesions, erythroderma, cutaneous granulomas, dysplasia of skin, hair, and nails, autoimmune conditions, and frank vasculitis. For the patient with suspected primary immunodeficiency, much can be inferred by evaluating the presenting cutaneous findings, including various infectious susceptibilities, presence of atopy, and evidence of impaired or overactive inflammatory response. The skin manifestations of primary immune deficiency diseases are often early or heralding findings of the underlying immunologic disease. Therefore, awareness of associations between skin findings and immune deficiency may aide in the early detection and treatment of serious or life-threatening immunologic defects. This review summarizes the common skin manifestations of primary immune deficiency diseases and provides the reader with a differential diagnosis of primary immune defects to consider for the most common skin manifestations.
Literature
1.
go back to reference Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C et al (2011) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2:54PubMedCentralPubMedCrossRef Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C et al (2011) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2:54PubMedCentralPubMedCrossRef
2.
go back to reference Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R (2000) Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol 17:91–96PubMedCrossRef Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R (2000) Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol 17:91–96PubMedCrossRef
3.
go back to reference Moin A, Farhoudi A, Moin M, Pourpak Z, Bazargan N (2006) Cutaneous manifestations of primary immunodeficiency diseases in children. Iran J Allergy Asthma Immunol 5:121–126PubMed Moin A, Farhoudi A, Moin M, Pourpak Z, Bazargan N (2006) Cutaneous manifestations of primary immunodeficiency diseases in children. Iran J Allergy Asthma Immunol 5:121–126PubMed
4.
go back to reference Al-Herz W, Nanda A (2011) Skin manifestations in primary immunodeficient children. Pediatr Dermatol 28:494–501PubMedCrossRef Al-Herz W, Nanda A (2011) Skin manifestations in primary immunodeficient children. Pediatr Dermatol 28:494–501PubMedCrossRef
5.
go back to reference Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16–22PubMedCentralPubMedCrossRef Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16–22PubMedCentralPubMedCrossRef
6.
go back to reference Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59PubMedCrossRef Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59PubMedCrossRef
7.
go back to reference Boxer LA, Newburger PE (2007) A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 49:609–614PubMedCrossRef Boxer LA, Newburger PE (2007) A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 49:609–614PubMedCrossRef
8.
go back to reference Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M et al (2006) Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107:4857–4864PubMedCrossRef Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M et al (2006) Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107:4857–4864PubMedCrossRef
9.
go back to reference Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM et al (2006) Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 108:81–87PubMedCrossRef Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM et al (2006) Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 108:81–87PubMedCrossRef
10.
go back to reference Spritz RA (1999) Multi-organellar disorders of pigmentation: tied up in traffic. Clin Genet 55:309–317PubMedCrossRef Spritz RA (1999) Multi-organellar disorders of pigmentation: tied up in traffic. Clin Genet 55:309–317PubMedCrossRef
11.
go back to reference Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol 131:67–73PubMedCentralPubMedCrossRef Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol 131:67–73PubMedCentralPubMedCrossRef
12.
go back to reference Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC et al (2012) Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148:79–84PubMedCrossRef Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC et al (2012) Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148:79–84PubMedCrossRef
14.
go back to reference Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885PubMedCrossRef Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885PubMedCrossRef
15.
go back to reference Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731–737PubMedCrossRef Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731–737PubMedCrossRef
16.
go back to reference Marrella V, Maina V, Villa A (2011) Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol 11:525–531PubMedCrossRef Marrella V, Maina V, Villa A (2011) Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol 11:525–531PubMedCrossRef
17.
go back to reference Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142PubMedCrossRef Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142PubMedCrossRef
18.
go back to reference Renner ED, Hartl D, Rylaarsdam S, Young ML, Monaco-Shawver L, Kleiner G et al (2009) Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536–543PubMedCentralPubMedCrossRef Renner ED, Hartl D, Rylaarsdam S, Young ML, Monaco-Shawver L, Kleiner G et al (2009) Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536–543PubMedCentralPubMedCrossRef
19.
go back to reference Sehgal VN, Srivastava G, Sardana K (2004) Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 43:39–47PubMedCrossRef Sehgal VN, Srivastava G, Sardana K (2004) Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 43:39–47PubMedCrossRef
20.
go back to reference Al-Dhalimi MA (2007) Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 34:302–307PubMedCrossRef Al-Dhalimi MA (2007) Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 34:302–307PubMedCrossRef
21.
22.
go back to reference Traupe H (1989) The Comèl–Netherton syndrome. The Ichthyoses: Springer Berlin, Heidelberg, pp 168–178 Traupe H (1989) The Comèl–Netherton syndrome. The Ichthyoses: Springer Berlin, Heidelberg, pp 168–178
23.
go back to reference de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N et al (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s syndrome). J Clin Invest 87:1352–1359PubMedCentralPubMedCrossRef de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N et al (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s syndrome). J Clin Invest 87:1352–1359PubMedCentralPubMedCrossRef
24.
go back to reference Le Deist F, Raffoux C, Griscelli C, Fischer A (1987) Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol 138:423–427PubMed Le Deist F, Raffoux C, Griscelli C, Fischer A (1987) Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol 138:423–427PubMed
25.
go back to reference Anderson KC, Weinstein HJ (1990) Transfusion-associated graft-versus-host disease. N Engl J Med 323:315–321PubMedCrossRef Anderson KC, Weinstein HJ (1990) Transfusion-associated graft-versus-host disease. N Engl J Med 323:315–321PubMedCrossRef
26.
go back to reference Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585–593, quiz 594PubMedCrossRef Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585–593, quiz 594PubMedCrossRef
27.
go back to reference Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S (2010) Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol 145:783–788PubMed Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S (2010) Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol 145:783–788PubMed
28.
go back to reference Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H (1991) Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J 67:291–294PubMedCentralPubMedCrossRef Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H (1991) Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J 67:291–294PubMedCentralPubMedCrossRef
29.
go back to reference Koskinen S (1996) Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 16:165–170PubMedCrossRef Koskinen S (1996) Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 16:165–170PubMedCrossRef
30.
go back to reference Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836PubMedCrossRef Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836PubMedCrossRef
31.
go back to reference Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622–e627PubMedCrossRef Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622–e627PubMedCrossRef
32.
33.
go back to reference Dohil M, Prendiville JS, Crawford RI, Speert DP (1997) Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 36:899–907PubMedCrossRef Dohil M, Prendiville JS, Crawford RI, Speert DP (1997) Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 36:899–907PubMedCrossRef
34.
go back to reference Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef
35.
go back to reference Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ et al (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251–261CrossRef Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ et al (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251–261CrossRef
36.
go back to reference Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(−)IgD(−)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551PubMedCrossRef Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(−)IgD(−)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551PubMedCrossRef
37.
go back to reference Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S et al (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385–400PubMedCrossRef Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S et al (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385–400PubMedCrossRef
38.
go back to reference Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C (2008) Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 128:314–321PubMedCentralPubMedCrossRef Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C (2008) Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 128:314–321PubMedCentralPubMedCrossRef
39.
go back to reference Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD (2006) Dermatological manifestations of autoimmune polyendo-crinopathy–candidiasis–ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093PubMedCrossRef Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD (2006) Dermatological manifestations of autoimmune polyendo-crinopathy–candidiasis–ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093PubMedCrossRef
40.
go back to reference Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(1169–1177):e1116 Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(1169–1177):e1116
41.
go back to reference Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M et al (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112:1108–1115PubMedCentralPubMedCrossRef Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M et al (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112:1108–1115PubMedCentralPubMedCrossRef
42.
go back to reference Notarangelo LD, Roifman CM, Giliani S (2008) Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol 8:534–539PubMedCrossRef Notarangelo LD, Roifman CM, Giliani S (2008) Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol 8:534–539PubMedCrossRef
43.
go back to reference Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12:753–764PubMedCrossRef Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12:753–764PubMedCrossRef
44.
go back to reference Dokal I (2011) Dyskeratosis congenita. Hematol Am Soc Hematol Educ Program 2011:480–486CrossRef Dokal I (2011) Dyskeratosis congenita. Hematol Am Soc Hematol Educ Program 2011:480–486CrossRef
45.
go back to reference Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P et al (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107:335–339PubMedCrossRef Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P et al (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107:335–339PubMedCrossRef
46.
go back to reference Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N et al (1999) Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23:421–424PubMedCrossRef Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N et al (1999) Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23:421–424PubMedCrossRef
47.
go back to reference Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169CrossRef Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169CrossRef
48.
go back to reference Windhorst DB, Good RA (1971) Dermatologic manifestations of fatal granulomatous disease of childhood. Arch Dermatol 103:351–357PubMedCrossRef Windhorst DB, Good RA (1971) Dermatologic manifestations of fatal granulomatous disease of childhood. Arch Dermatol 103:351–357PubMedCrossRef
49.
go back to reference Nord KM, Pappert AS, Grossman ME (2011) Pyoderma gangrenosum-like lesions in leukocyte adhesion deficiency I treated with intravenous immunoglobulin. Pediatr Dermatol 28:156–161PubMedCrossRef Nord KM, Pappert AS, Grossman ME (2011) Pyoderma gangrenosum-like lesions in leukocyte adhesion deficiency I treated with intravenous immunoglobulin. Pediatr Dermatol 28:156–161PubMedCrossRef
50.
go back to reference Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH (2010) Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol 27:500–503PubMedCrossRef Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH (2010) Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol 27:500–503PubMedCrossRef
51.
go back to reference Paller AS, Nanda V, Spates C, O’Gorman M (1994) Leukocyte adhesion deficiency: recurrent childhood skin infections. J Am Acad Dermatol 31:316–319PubMedCrossRef Paller AS, Nanda V, Spates C, O’Gorman M (1994) Leukocyte adhesion deficiency: recurrent childhood skin infections. J Am Acad Dermatol 31:316–319PubMedCrossRef
53.
go back to reference Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99PubMedCrossRef Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99PubMedCrossRef
54.
go back to reference Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL (2001) Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1:503–511PubMedCrossRef Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL (2001) Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1:503–511PubMedCrossRef
55.
go back to reference Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S et al (2001) Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 18:205–209PubMedCrossRef Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S et al (2001) Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 18:205–209PubMedCrossRef
57.
go back to reference Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129:294–305, quiz 306–297PubMedCrossRef Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129:294–305, quiz 306–297PubMedCrossRef
58.
go back to reference Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H et al (2009) Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 124:342–348, 348 e341-345PubMedCentralPubMedCrossRef Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H et al (2009) Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 124:342–348, 348 e341-345PubMedCentralPubMedCrossRef
59.
go back to reference Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12:616–622PubMedCentralPubMedCrossRef Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12:616–622PubMedCentralPubMedCrossRef
60.
go back to reference Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767PubMedCentralPubMedCrossRef Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767PubMedCentralPubMedCrossRef
61.
go back to reference Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A et al (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208:1635–1648PubMedCentralPubMedCrossRef Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A et al (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208:1635–1648PubMedCentralPubMedCrossRef
62.
go back to reference van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C et al (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54–61PubMedCrossRef van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C et al (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54–61PubMedCrossRef
63.
go back to reference Drewniak AA, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL et al (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385-2392 Drewniak AA, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL et al (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385-2392
64.
go back to reference Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735PubMedCentralPubMedCrossRef Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735PubMedCentralPubMedCrossRef
65.
go back to reference Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C et al (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297PubMedCentralPubMedCrossRef Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C et al (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297PubMedCentralPubMedCrossRef
66.
go back to reference Chatzipanagiotou S, Takou K, Perogamvros A (1998) Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 41:379–382PubMedCrossRef Chatzipanagiotou S, Takou K, Perogamvros A (1998) Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 41:379–382PubMedCrossRef
67.
go back to reference Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ et al (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055PubMedCentralPubMedCrossRef Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ et al (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055PubMedCentralPubMedCrossRef
68.
go back to reference Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581PubMedCrossRef Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581PubMedCrossRef
69.
go back to reference Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F et al (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70–74PubMedCrossRef Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F et al (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70–74PubMedCrossRef
Metadata
Title
Skin Manifestations of Primary Immune Deficiency
Author
Heather Lehman
Publication date
01-04-2014
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 2/2014
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-013-8377-8

Other articles of this Issue 2/2014

Clinical Reviews in Allergy & Immunology 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.